1. J. Jiang, L. Huang, X. Liang, et al., Gefitinib versus docetaxel in previously treated advanced non-small-cell lung
2. N. Li, W. Ou, X. Ye, et al., Pemetrexed-carboplatin adjuvant chemotherapy with or without gefitinib in resected stage IIIA-N2 non-small cell lung cancer harbouring EGFR
3. X. Yang, K. Yang and K. Kuang, The efficacy and safety of EGFR inhibitor monotherapy in non-small cell lung
4. C. Zhou, Y. L. Wu, G. Chen, et al., Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL,
5. T. Cufer, T. Ovcaricek and M. E. O'Brien, Systemic therapy of advanced non-small cell lung